
The MedTech Convention is meant to inform and inspire all students interested in the fascinating world of medical technology. Key figures in the MedTech sector in Belgium will give a keynote about their innovative medical technologies, and how they are shaping the future of healthcare.
Before and after the keynotes, you get to connect and ask questions to fast-growing, innovative companies all working on various topics within medical technology. Our booth fair allows companies to showcase what they are working on, and how they see healthcare evolving.
Are you a medicine student who wants to know more about what you'll be working with in the future, are you a tech-enthusiast who can't wait to innovate healthcare, or are you simply interested in how you will experience healthcare in the future? The MedTech Convention is the place to be!
19:00 Doors open & Booth Fair Part 1
Booth fair & networking until 20:25
20:30 Seating opens in Vesalius Hall
20:40 Welcome & introduction by NEXT
20:45 Prof. Dr. Peter Stalmans
21:00 Julie Coorevits
21:15 Dr. Henri Van Overmeire
21:30 Wrap-up & thanks
21:35 Booth Fair Part 2 & networking reception
23:00 The end
.jpg)
Are you a student with a great idea, but no startup yet? Get a chance to pitch in front of AI experts and meet other founders:
Apply here!

Peter Stalmans works as a staff member in the Ophthalmology Department at UZ Leuven and as a lecturer at KU Leuven. He obtained his degree in medicine, surgery, and obstetrics at KU Leuven. He trained as an ophthalmologist at UZ Leuven, complemented by a one-year fellowship in vitreoretinal surgery at the Rotterdam Eye Hospital. He has been working as a staff member at UZ Leuven since 2000, as a lecturer at KU Leuven since 2001, and became head of clinic in 2016.
Professor Stalmans is a board member of the Belgian Ophthalmological Society (BOG), and a member of the AAO, ARVO, Belgian Retinal Society (BRS), EVER, ASRS, EVRS, and EURETINA. He organized the international Leuven Retina Meeting in 2011, 2013, 2015, and 2017. He has delivered presentations at various national and international meetings and has published more than 80 manuscripts in peer-reviewed journals.
Professor Stalmans was the principal investigator in several phase 2 ocriplasmin (Jetrea) studies and was the coordinating investigator of the MIVI TRUST phase 3 trials, which were published in The New England Journal of Medicine. In 2017, he performed the first successful robotic retinal vein cannulation. In 2020, he implanted the first Nano-Retina bionic retinal implant in a phase 1 study.
His professional interests include vitreoretinal surgery, development of surgical instruments and devices, bionic visual prostheses, robotic eye surgery, 3D digital surgery, and pharmacologic vitreolysis.


Julie Coorevits is a Belgian tech enthusiast with a passion for cybersecurity and AI. With around 7 years in enterprise SaaS at Robovision, Intigriti and Barco, she was selected for the Prince Albert Fund, which brought her to Silicon Valley. Based in San Francisco from January 2025, she served as Account Manager at Barco, leading MedTech partnerships with NVIDIA for its AI surgical display line, while deepening her technical knowledge through Stanford Python and AI courses.
In Silicon Valley she won the Plug and Play Business Innovation Sprint Hackathon and received the VBO NextGen Leadership Award in 2026. She now works at Enokilabs.ai, a Ghent based startup that focuses on AI agent security. Beyond her work, she is a board member of the Belgian Club of Northern California, built newinsf.com, a practical starter guide for Belgians moving to San Francisco, and helps people keep their data safe online via onlinesecuritybasics.com.


Henri Van Overmeire’s path runs from physics and astronomy through medicine to biomedical engineering. He is a resident in anesthesiology, is completing a PhD on semantic artificial intelligence in anesthesia and critical care at Ghent University, and is the founder and Chief Medical Officer of PointCaré.
PointCaré builds ontarget, a clinical decision support platform that brings patient data, device data and medical knowledge together to support clinicians before, during and after surgery. From preoperative preparation to real-time support in the operating room and ICU, it turns scattered information into evidence-based insights, helping clinicians understand what matters and why.



Nucleate Ambassadors Belgium is part of Nucleate, a global, trainee-led non-profit that helps bachelor and master students, PhD researchers and postdocs turn academic discoveries into companies. Working across Belgium, Europe and globally, we run free programming in intellectual property, venture capital, business development, consulting and entrepreneurship. This includes the Global Virtual Activator, a startup accelerator named by The Times among the best in the US. We want every student and scientist in Belgium to have the chance to learn how companies are built, with no fees and no equity taken.
_nFO9KbWTUl4l10YtUVel4.png)
_nFO9KbWTUl4l10YtUVel4.png)
Biomedix is the student circle run by and for Biomedical Engineering students in Leuven. Our goal is to bring students together, create lasting connections and strengthen the sense of community within our programme. We organise a wide range of events and activities, offering students opportunities to meet one another, have fun and discover more about the Biomedical Engineering field beyond the classroom. Through these experiences, we aim to connect students with each other and the real-world applications of their future profession.


Since 2020, this CHIMES branch has been enthusiastically represented by a dedicated team of Leuven students. In the 2026–2027 academic year, a board of 12 motivated aspiring doctors is committed to achieving the goals of CHIMES. Through various events, such as workshops, lectures, and conferences, they aim to inspire their fellow students to enrich their surgical knowledge.


Junior Orsi Academy is the student initiative of Orsi Academy, a renowned training centre for robotic surgery. We bring together students from all backgrounds who share an interest in innovation in healthcare, with multidisciplinarity at the core of everything we do. Through hands-on events, lectures and workshops, students discover robotic surgery and medical technology. With the Junior Orsi Fellowships, students gain international experience at leading institutions, including Harvard in Boston and partners in London, where economics and law students can now take part as well. Through the Junior Orsi Research Program, motivated young researchers join real research projects with Orsi Academy and Mantyx. Together, we prepare the next generation for the healthcare of tomorrow.
Xyall is a young Dutch company based in Eindhoven that has developed a novel solution for tumor tissue sample selection for molecular diagnostics in oncology. The company is in a scaling phase. It has already placed 25+ Tissector TT* instruments at leading molecular diagnostic companies, pharma and hospitals, mainly in the US. Tissector TT is an automated tumor enrichment platform that enables laboratories to consistently dissect tumor tissue samples with high accuracy, reliability, and efficiency.
* for Research Use Only
Itsunto develops Chorus, an AI platform for complex patient cases. Chorus brings relevant virtual specialists together around a single case, grounds their perspectives in biomedical literature, and lets them challenge and refine each other’s reasoning toward a traceable clinical synthesis.
With Chorus Academy, the same approach is applied to training: physicians in training can practise on fictional cases, participate in virtual expert panels, and strengthen their clinical reasoning in a safe learning environment.
Through Chorus, Itsunto supports human decision-making rather than replacing it.
Man & Science is a Belgian medtech company based in Liège, developing implantable neurostimulation devices for severe headache disorders. Its lead product, an occipital nerve stimulator, treats refractory chronic cluster headache, one of the most painful conditions known, for which few options exist today. A second platform, an injectable micro-stimulator, is in development for acute headache, including migraine. The company combines miniaturised electronics, implant engineering and clinical research to bring new relief to patients and simplify physicians’ procedures.


“No patient should suffer due to an error caused by incorrect or missing clinical data.” CGM LAB Belgium develops and markets “MOLIS,” a state-of-the-art Laboratory Information System (LIS) designed to optimize workflows, traceability, and diagnostic quality. Interoperable and secure, it connects instruments, data, and teams to accelerate reliable results from specimen collection through to biological validation. Used by numerous laboratories across Europe, MOLIS offers an innovative environment where science, data, IT, and healthcare converge.



As Belgium’s leading university hospital, UZ Leuven continues to redefine healthcare by merging advanced treatment with compassionate, patient-centered care. Daily, our dedicated team of nearly 10,000 professionals works to deliver top-tier, tailored medical solutions. We are deeply committed to empowering future healthcare leaders through continuous learning, cutting-edge training, and pioneering medical innovation. By bridging clinical expertise with breakthrough research, UZ Leuven remains at the forefront of transforming patient outcomes for tomorrow.


Lynqo is an Antwerp-based healthtech startup building computer vision technology that understands what happens in the OR. Surgical teams still rely heavily on manual registration, experience and conversations to keep track of instruments and procedure progress. We turn that activity into reliable information, supporting instrument counting, automating registration and helping teams anticipate what comes next. Our ambition is to make surgery safer and more efficient, reduce pressure on clinical teams and help hospitals make better use of their operating rooms.
Founded in 2024 by Kaat, Felix and Frédéric, Lynqo works closely with Belgian and Dutch hospitals. We develop and test our technology alongside surgical teams, translating the realities of the OR into software that works in practice.


Sentigrate is a data company specialized in processing, modeling and visualizing sensor data. Today, the company is headquartered in Leuven with a wide range of customers from university spin-offs to multinationals. We are active in more than 16 countries and have experience with different types of projects ranging from proof-of-concepts to projects with over 1.5 million sensors.
We have a proven track record when it comes to integrating and combining multi-parameter sensor data and building machine learning methodologies to extract insights and knowledge in a fast and proactive way. Together we can leverage your data into new opportunities.


Cryotherapeutics is an early-stage innovator developing a novel, minimally invasive, catheter-based cryotherapy system designed to target coronary vulnerable plaques, a major underlying cause of myocardial infarction and responsible for approximately 75% of fatal cardiac events.
Want to help organise the next edition? Apply here

